Latest Breaking News On - Therapeutix stock down - Page 1 : comparemela.com

Ocular Therapeutix (OCUL) Set to Announce Earnings on Monday

Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) is set to release its earnings data after the market closes on Monday, March 11th. Analysts expect Ocular Therapeutix to post earnings of ($0.28) per share for the quarter. Ocular Therapeutix Stock Down 3.8 % Shares of NASDAQ OCUL opened at $9.98 on Friday. The company’s 50-day simple […]

United statesPiper sandlerRabia gurses ozdenSecurities exchange commissionHermes incMarshall waceRenaissance technologiesOcular therapeutix incNuveen asset managementVanguard group incOcular therapeutixGet free reportTherapeutix stock downExchange commissionSummer road llcAsset management

Ocular Therapeutix, Inc (NASDAQ:OCUL) General Counsel Sells $33,813 45 in Stock

Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) General Counsel Philip C. Strassburger sold 6,831 shares of the firm’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $4.95, for a total transaction of $33,813.45. Following the transaction, the general counsel now directly owns 109,218 […]

United statesPhilipc strassburgerChina universal asset management coDeltec asset managementSecurities exchange commissionRelyea zuckerberg hansonSimplicity solutionsRaymond james associatesOcular therapeutix incOcular therapeutixGet free reportGeneral counsel philipExchange commissionTherapeutix stock downUniversal asset managementAsset management

Ocular Therapeutix, Inc (NASDAQ:OCUL) CFO Donald Notman Sells 6,433 Shares of Stock

Ocular Therapeutix, Inc (NASDAQ:OCUL) CFO Donald Notman Sells 6,433 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesDonald notmanMarshall waceSectoral asset management incOcular therapeutix incHermes incNuveen asset managementOcular therapeutixGet free reportTherapeutix stock downAsset managementResure sealantOcular therapeutix daily

Ocular Therapeutix, Inc (NASDAQ:OCUL) General Counsel Philip C Strassburger Sells 6,831 Shares of Stock

Ocular Therapeutix, Inc (NASDAQ:OCUL) General Counsel Philip C Strassburger Sells 6,831 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPhilipc strassburgerJpmorgan chase coOcular therapeutix incPanagora asset management incSwiss national bankOcular therapeutixGet free reportGeneral counsel philipTherapeutix stock downNational bankMontreal canAsset managementCetera investment advisersInvestment advisersResure sealant

Ocular Therapeutix (NASDAQ:OCUL) Rating Increased to Hold at StockNews com

Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Wednesday. Several other research analysts have also weighed in on the company. Robert W. Baird boosted their price target on Ocular Therapeutix from $10.00 to $12.00 in […]

United statesRobertw bairdVanguard group incDeltec asset managementOcular therapeutix incBlackrock incOcular therapeutixGet free reportTherapeutix stock downAsset managementState street corpStreet corpResure sealantOcular therapeutix dailyNasdaq oculStocknews com